Bumrungrad International Hospital
Chemoembolization of the liver in Thailand typically costs from AUD $10,715 / ฿A364,300 to AUD $15,001 / ฿A510,020. Prices depend on the clinic tier, the number of required sessions, and the specific chemotherapy drugs used. In Australia, this procedure costs AUD $17,715 / ฿A602,309 on average. Patients save approximately 27% by choosing Thai medical centres. Fees usually cover the hospital stay, oncologist consultations, oncology drugs, and basic diagnostic tests.
Bookimed Expert Insight: Choosing a globally recognised facility provides significant value for complex oncology cases. Bumrungrad International Hospital is ranked among the world's TOP-10 hospitals and holds Joint Commission International (JCI) accreditation. This ensures adherence to strict global safety standards. Their massive outpatient capacity and 1,300 doctors allow for rapid treatment Commencement. This is vital for Australian patients facing long public waitlists at home.
| Thailand | Turkey | South Korea | |
| Chemoembolization of the liver | from AUD $10,715 / ฿A364,300 | from AUD $10,715 / ฿A364,300 | from AUD $6,857 / ฿A233,152 |
No hidden fees – just official clinic prices. Pay at the clinic for Chemoembolization of the liver upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chemoembolization of the liver and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chemoembolization of the liver journey.
Chemoembolisation (TACE) in Thailand offers a strong safety profile and survival benefits for liver cancer. Median survival typically reaches 21.4 months for intermediate-stage patients. Leading centres like Bumrungrad International Hospital maintain JCI and Global Healthcare Accreditation. These hospitals provide highly regulated, minimally invasive care for international patients.
Bookimed Expert Insight: Thailand is a global hub for liver cancer because the disease is prevalent there. This high patient volume means centres like Bumrungrad International handle 1,000,000+ patients annually. Their specialists have vast experience managing complex cases. This includes patients with more advanced cirrhosis who might be rejected for TACE in Australia.
Patient Consensus: Patients often highlight the efficiency of being diagnosed and treated within one trip. They value the clear communication from international departments and the seamless coordination of follow-up care.
Transarterial chemoembolisation (TACE) in Thailand suits patients with primary liver cancer or liver metastases. It is used when tumours cannot be surgically removed. Candidates need stable liver function and tumours smaller than 10 cm. These must occupy less than 50% of the liver volume.
Bookimed Expert Insight: Thai hospitals often accept patients with Child-Pugh scores of 7 or 8. This is more flexible than many Western protocols. Large centres like Bumrungrad International Hospital serve over 1,000,000 patients annually. They use this expertise to treat complex cases safely.
Patient Consensus: Patients found that providing recent CT or MRI scans early helped specialists. These scans confirm if tumours have the arterial blood supply needed for TACE. Most noted that being fit for travel was essential for their recovery in Thailand.
The most common side effect following TACE in Thailand is post-embolisation syndrome. This affects 40% to 68% of patients within 72 hours of treatment. Symptoms include abdominal pain, low-grade fever, nausea, and fatigue. These signs typically indicate the treatment is working as tumour tissue breaks down.
Bookimed Expert Insight: JCI-accredited centres like Bumrungrad International Hospital manage many international patients. Data shows side effect severity often depends on the liver volume treated. Australians should confirm if their overnight stay includes specific anti-nausea drug regimens.
Patient Consensus: Expect a heavy ache in the liver area and flu-like symptoms for several days. Patients recommend planning for low energy and reduced activity while recovering from tiredness.
Liver chemoembolisation in Thailand takes 1 to 2 hours. This is followed by a 24 to 48-hour hospital stay. Most patients recover within 2 to 4 weeks. Hospitals like Bumrungrad International use real-time imaging to target tumours while sparing healthy tissue.
Bookimed Expert Insight: Thai hospitals like Bumrungrad International offer telemedicine for remote follow-up. This is vital because tumour response scans occur 4–12 weeks after treatment. Patients can return to Australia once stable and manage these evaluations from home.
Patient Consensus: Thai medical teams manage the difficult first 72 hours with effective pain and nausea protocols. International patients recommend staying locally for several extra days before flying home. This helps make sure symptoms like fatigue have fully passed.
Transarterial chemoembolisation (TACE) treats liver cancer by delivering high-dose chemotherapy directly to tumours while blocking their blood supply. This procedure uses a catheter to target the hepatic artery. It starves cancer cells of oxygen and traps medication inside the site for the best effect.
Bookimed Expert Insight: Thailand’s leading centres like Bumrungrad International Hospital serve over 1,000,000 patients annually with JCI-accredited precision. Data shows TACE is often used as a bridge therapy. It keeps tumours small enough for future transplants or surgical resection.
Patient Consensus: Expect post-embolisation syndrome including mild fever and nausea during the initial recovery in Thailand. Patients feel reassured that the treatment targets only the cancer and spares healthy liver tissue.
Recommended hospitals for liver chemoembolisation (TACE) in Thailand include JCI-accredited facilities such as Bumrungrad International Hospital and Vejthani Hospital. These centres feature catheterisation laboratories (Cath Labs) and multidisciplinary tumour boards. Specialists use image-guided technology to deliver localised chemotherapy directly to liver tumours. This approach helps minimise systemic effects.
Bookimed Expert Insight: Bumrungrad International serves over 1,000,000 patients annually, with 50% being international visitors. This high volume across 70 departments means that multidisciplinary teams are used to coordinating complex liver cancer cases. These teams include interventional radiologists and hepatologists who work with overseas patients.
Patient Consensus: Australians often look for reports on in-hospital monitoring and outpatient oncology follow-up. Clear English medical reports are a priority for a smooth handover to local specialists back home.